Accelerator Plus 10 review

It depends on how long you plan to hold it. For a buyer who is genuinely committed to a 10-year horizon, the vesting bonus provides a real head start on accumulation. For someone who might need to access principal in the first four to five years, the surrender charges are severe enough to offset most of the bonus. The chronic illness waiver is a meaningful inclusion that reduces one of the main objections to locking money into a long-duration annuity. On balance, this is a good product for the right buyer, but the qualifier matters more here than with most FIAs.

The vesting bonus is the primary driver. An 11% credit at contract issue gives the account value an immediate lift that no index-linked crediting strategy can match in year one. The secondary reason is flexibility: the contract can run as a pure accumulation vehicle or, with the optional income rider added, function as a future income platform. Buyers who want both optionality and a meaningful starting advantage in one contract will find the combination appealing.

I think Accelerator Plus 10 is best for a buyer in the 55-to-70 range who is funding the contract with money they are confident they will not touch for at least the back half of the surrender period. It works well in a qualified account where the 10-year time horizon is realistic and RMD timing can be managed within the free-withdrawal provision. It is less well suited for someone approaching a near-term income need, someone building a shorter-duration annuity ladder, or someone who wants the simplest possible fee structure without rider complexity.

You are not buying a market investment. You are buying an insurance contract that starts by crediting a vesting bonus to your account, then uses index-linked formulas to potentially grow that account over time, while protecting principal from direct market losses. The bonus gives you a larger starting balance than your premium alone. The indexed crediting then attempts to build on that base. The income rider, if added, converts a portion of that balance into a future withdrawal guarantee. The actual mechanics depend on which crediting strategies you choose and whether you activate the income feature.

The vesting bonus is applied to the account value at contract issue — 11% for most buyers under 76. That means a $100,000 premium starts with approximately $111,000 in account value immediately. From there, you choose among indexed crediting strategies. The contract offers point-to-point annual strategies tied to seven indices: S&P 500, Balanced Asset 5, Balanced Asset 10, Barclays Trailblazer Sectors 5, BlackRock Market Advantage, GS Global Factor, and Morgan Stanley US Equity Allocator. A fixed account option credited at a minimum of 3.75% is also available.

The critical detail is that certain index strategies carry a 1.25% annual fee. Specific participation rates, caps, and spreads for each index were not available in the brochure materials — if you are comparing this product to others, ask for the current rate sheet to do a real apples-to-apples comparison. An MVA — Market Value Adjustment, meaning your surrender penalty can fluctuate with interest rates — applies to withdrawals above the free amount during the surrender period.

The optional income rider — Enhanced Guaranteed Minimum Withdrawal Benefit V — is the most consequential secondary feature. For buyers who add it, the rider charges 0.95% annually on the income base and applies a 5% compound annual interest credit to that base during the deferral period. That means the income base grows even in years when the account earns nothing. The 5% compound roll-up is a meaningful guarantee: it gives the buyer a defined growth target for the income base regardless of index performance.

The chronic illness waiver in the base contract is also worth noting. If you qualify as chronically ill or enter long-term care, the contract waives surrender charges on withdrawals for qualifying expenses, which materially changes the liquidity picture for a buyer with health concerns.

This contract is designed for long-term money. Free withdrawals are available up to 10% of the vested account value per year after the first contract year — note that in year one, no free withdrawals are available. Withdrawals above the free amount trigger the surrender charge schedule and an MVA.

The surrender schedule opens at 14% in year one and steps down gradually. That is a steeper opening charge than many comparable 10-year FIAs, which often start at 10%. It reflects the cost of the vesting bonus. The practical implication is that someone who needs money in the first few years could lose not only the bonus advantage but a portion of their original premium.

The chronic illness waiver provides meaningful relief: qualifying long-term care expenses — home health care, nursing home, and terminal illness — may be withdrawn without surrender charges if the waiver conditions are met. Required minimum distributions are also generally handled without surrender charge, though they still count against the free-withdrawal allowance.

There is no base contract fee. The optional income rider costs 0.95% annually on the income base — that is the main explicit ongoing charge for buyers who elect it. Certain index strategies add a 1.25% annual fee on top of that. If you are using a fee-bearing strategy and carrying the income rider, you are running roughly 2.20% in annual charges before any other costs. That is a real drag on accumulation in low-growth environments.

The subtler tradeoff is the relationship between the bonus and the surrender schedule. The 11% vesting credit is genuinely valuable, but the 14% year-one surrender charge means the net position is negative in year one if you exit. The contract requires meaningful commitment to deliver on its headline promise. Buyers should approach it as a 7-to-10-year hold, not a 3-to-5-year hold with an exit option.

Legal Entity: Fidelity & Guaranty Life Insurance Company

Parent: Fidelity National Financial, Inc.

F&G has been an active player in the indexed annuity market for decades, with a product lineup concentrated in FIA and MYGA designs. Financial strength ratings were not available in the extracted materials — if carrier credit quality is a priority for you, request current ratings directly from F&G or your advisor before purchase.